News

DailyUpdates 11 th August: Lipoxin A4 (LXA4) mimics shown reduce inflammation by inhibiting the p38-MAPK pathway-further proof of concept for LXA4 analogues in preclinical development The p38-MAPK ...
Given that none of the upstream kinases in the MAP kinase pathway contains a heme moiety, a common target for CO, and our observation that CO mediated anti-inflammatory effects through cGMP ...